Skip to main content

Cutaneous Merkel Cell Carcinoma

  • Chapter
  • First Online:
Book cover Radiation Therapy for Skin Cancer
  • 2190 Accesses

Abstract

Merkel cell carcinoma is a rare cutaneous neuroendocrine malignancy that usually presents as a small (<2 cm) skin lesion without evidence of regional or distant disease. The diagnostic evaluation includes a chest radiograph, computed tomography of the regional lymph nodes, and positron emission tomography. Treatment consists of excision of the primary lesion and any positive regional nodes followed by postoperative radiotherapy to the primary site and regional lymphatics. The efficacy of adjuvant chemotherapy is unproven and it is not routinely employed. The 5-year local-regional control rate is approximately 80–90 %. The dominant mode of failure is distant. The 5-year cause-specific and overall survival rates are approximately 40–50 %. The likelihood of severe treatment complications is relatively low.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105(1):107–10.

    Article  PubMed  CAS  Google Scholar 

  2. Asioli S, Righi A, Volante M, Eusebi V, Bussolati G. p63 expression as a new prognostic marker in Merkel cell carcinoma. Cancer. 2007;110(3):640–7.

    Article  PubMed  Google Scholar 

  3. Andea AA, Coit DG, Amin B, Busam KJ. Merkel cell carcinoma: histologic features and prognosis. Cancer. 2008;113(9):2549–58.

    Article  PubMed  Google Scholar 

  4. Koljonen V, Kukko H, Tukiainen E, Bohling T, Sankila R, Joensuu H, et al. Second cancers following the diagnosis of Merkel cell carcinoma: a nationwide cohort study. Cancer Epidemiol. 2010;34(1):62–5.

    Article  PubMed  Google Scholar 

  5. Bhatia K, Goedert JJ, Modali R, Preiss L, Ayers LW. Immunological detection of viral large T antigen identifies a subset of Merkel cell carcinoma tumors with higher viral abundance and better clinical outcome. Int J Cancer. 2010;127(6):1493–6.

    Article  PubMed  CAS  Google Scholar 

  6. Samlowski WE, Moon J, Tuthill RJ, Heinrich MC, Balzer-Haas NS, Merl SA, et al. A phase II trial of imatinib mesylate in Merkel cell carcinoma (neuroendocrine carcinoma of the skin): a Southwest Oncology Group study (S0331). Am J Clin Oncol. 2010;33(5):495–9.

    Article  PubMed  CAS  Google Scholar 

  7. Mojica P, Smith D, Ellenhorn JD. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol. 2007;25(9):1043–7.

    Article  PubMed  Google Scholar 

  8. Heath M, Jaimes N, Lemos B, Mostaghimi A, Wang LC, Penas PF, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol. 2008;58(3):375–81.

    Article  PubMed  Google Scholar 

  9. Concannon R, Larcos GS, Veness M. The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia. J Am Acad Dermatol. 2010;62(1):76–84.

    Article  PubMed  Google Scholar 

  10. Gupta SG, Wang LC, Penas PF, Gellenthin M, Lee SJ, Nghiem P. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature. Arch Dermatol. 2006;142(6):685–90.

    Article  PubMed  Google Scholar 

  11. Poulsen MG, Rischin D, Porter I, Walpole E, Harvey J, Hamilton C, et al. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? Int J Radiat Oncol Biol Phys. 2006;64(1):114–9.

    Article  PubMed  Google Scholar 

  12. McAfee WJ, Morris CG, Mendenhall CM, Werning JW, Mendenhall NP, Mendenhall WM. Merkel cell carcinoma: treatment and outcomes. Cancer. 2005;104(8):1761–4.

    Article  PubMed  Google Scholar 

  13. Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK. Merkel cell carcinoma. Prognosis and management. Arch Surg. 1991;126(12):1514–9.

    Article  PubMed  CAS  Google Scholar 

  14. American Joint Committee on Cancer, editor. AJCC cancer staging handbook. 7th ed. Chicago: Springer; 2010.

    Google Scholar 

  15. Fang LC, Lemos B, Douglas J, Iyer J, Nghiem P. Radiation monotherapy as regional treatment for lymph node-positive Merkel cell carcinoma. Cancer. 2010;116(7):1783–90.

    Article  PubMed  Google Scholar 

  16. Bichakjian CK, Coit DG, Wong SL. Radiation versus resection for Merkel cell carcinoma. Cancer. 2010;116(7):1620–2.

    Article  PubMed  Google Scholar 

  17. Veness M, Foote M, Gebski V, Poulsen M. The role of radiotherapy alone in patients with merkel cell carcinoma: reporting the Australian experience of 43 patients. Int J Radiat Oncol Biol Phys. 2010;78(3):703–9.

    Article  PubMed  Google Scholar 

  18. Foote M, Harvey J, Porceddu S, Dickie G, Hewitt S, Colquist S, et al. Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin. Int J Radiat Oncol Biol Phys. 2010;77(3):677–84.

    Article  PubMed  Google Scholar 

  19. Clark JR, Veness MJ, Gilbert R, O'Brien CJ, Gullane PJ. Merkel cell carcinoma of the head and neck: is adjuvant radiotherapy necessary? Head Neck. 2007;29(3):249–57.

    Article  PubMed  Google Scholar 

  20. Medina-Franco H, Urist MM, Fiveash J, Heslin MJ, Bland KI, Beenken SW. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol. 2001;8(3):204–8.

    Article  PubMed  CAS  Google Scholar 

  21. Kim J, McNiff JM. Nuclear expression of survivin portends a poor prognosis in Merkel cell carcinoma. Mod Pathol. 2008;21(6):764–9.

    Article  PubMed  CAS  Google Scholar 

  22. Mendenhall WM, Kirwan JM, Morris CG, Amdur RJ, Werning JW, Mendenhall NP. Cutaneous Merkel cell carcinoma. Am J Otolaryngol. 2012;33(1):88–92.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William M. Mendenhall .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Mendenhall, W.M. (2013). Cutaneous Merkel Cell Carcinoma. In: Cognetta Jr., A., Mendenhall, W. (eds) Radiation Therapy for Skin Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6986-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6986-5_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6985-8

  • Online ISBN: 978-1-4614-6986-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics